Filana Therapeutics, Inc.
FLNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001069530
No open-market purchases or sales by Filana Therapeutics, Inc. insiders were filed in the last 90 days; 85 institutions reported holding it in 13F filings for Q2 2026, worth $15.1M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Filana Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- −5 vs. Q4 2025
- Shares held
- 13.6M
- +2.23M (+19.5%) vs. Q4 2025
- Total value
- $23.1M
- +$456.5K (+2.0%) vs. Q4 2025
- New holders
- 15
- 17 more added
- Sold out
- 20
- 37 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FLNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 85 | $15.1M |
| Q1 2026 | 101 | $23.1M |
| Q4 2025 | 107 | $27.3M |
| Q3 2025 | 103 | $40.1M |
| Q2 2025 | 97 | $22.1M |
| Q1 2025 | 117 | $23.6M |
| Q4 2024 | 137 | $41.1M |
| Q3 2024 | 161 | $412.5M |
| Q2 2024 | 145 | $164.6M |
| Q1 2024 | 142 | $235.3M |
| Q4 2023 | 153 | $313.5M |
| Q3 2023 | 141 | $215.4M |
| Q2 2023 | 152 | $286.8M |
| Q1 2023 | 145 | $287.9M |
| Q4 2022 | 153 | $332.5M |
| Q3 2022 | 174 | $438.9M |
| Q2 2022 | 149 | $279.2M |
| Q1 2022 | 163 | $390.2M |
| Q4 2021 | 171 | $504.1M |
| Q3 2021 | 181 | $757.3M |
| Q2 2021 | 169 | $893.4M |
| Q1 2021 | 128 | $458.2M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Filana Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 2,012,543 | $3.40M | 0.00% | −102,764−4.9% | Reduced |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −954,800−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −91,620−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −83,900−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −50,866−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −48,832−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −29,520−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −23,192−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −13,531−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −12,259−100.0% | Sold out |
| Fortis Capital Advisors, LLC | 0 | $0 | 0.00% | −12,259−100.0% | Sold out |
| SmartHarvest Portfolios, LLC | 0 | $0 | 0.00% | −12,072−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −7,073−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −5,026−100.0% | Sold out |
| Flagship Harbor Advisors, LLC | 0 | $0 | 0.00% | −620−100.0% | Sold out |
| Strategic Wealth Partners, Ltd. | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −110−100.0% | Sold out |
| Byrne Asset Management LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Laurel Wealth Advisors LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |